- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02585557
Heart Health NOW (Previously Known as FAST PACE NC) (HHN)
Heart Health NOW (Previously Known as Facilitation, Spread, and Translation of Patient-Centered Evidence in North Carolina Practices)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The burden of cardiovascular disease in North Carolina remains large. The latest data available show an annual cardiovascular death rate of 263 per 100,000 explaining almost one-third of deaths in the state. Disease progression is largely determined by several risk factors including elevated blood pressure or cholesterol, not using aspirin for prevention, and tobacco use. Primary care practices as currently organized have been unable to get more than half these patients to achieve recommended targets for risk factor reduction. Small independent practices, in particular, lack resources for enhanced practice support to improve cardiovascular care.
This study will enroll 300 primary care practices to evaluate the effect of primary care support on evidence-based cardiovascular disease (CVD) prevention and organizational change process measures. Each practice will start the trial as a control, receive the intervention at a randomized time point, and then enter a maintenance period 12 months after starting the intervention. All practices will receive 12 months of the intense intervention including onsite quality improvement (QI) facilitation, academic detailing, electronic health record (EHR) support, and, through the North Carolina Health Information Exchange (HIE), a shared statewide utility providing whole population analytics, care gap identification, benchmarking, and an external reporting mechanism which otherwise would not be available to independent practices.
A successful intervention would prove that practice facilitation supported by effective informatics tools is an effective method of translating PCOR findings into practice. Discernible reductions in cardiovascular risk in 300 practices covering over an estimated 900,000 adult patients would likely lead to prevention of thousands of cardiovascular events within 10 years.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary care practice in North Carolina with 10 or fewer providers in a single location
- must have implemented an EHR and either be connected to or have agreed to connect to the HIE.
Exclusion Criteria:
- practices with more than 10 providers in a single location
- practices receiving practice facilitation services beyond the usual support provided by Area Health Education Centers (AHEC) or the Community Care of North Carolina (CCNC) program through their parent organization.
- practices without an EHR
- practices where the central practice organization either bars the practice from our program or provides onsite facilitation services equal to or greater than the 4-6 hour standard contact with a QI coach
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cluster A
50 practices randomly assigned to start intervention at month 9. Assigned Intervention: Primary Care Practice Support.
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
Experimental: Cluster B
50 practices randomly assigned to start intervention at month 11.
Assigned Intervention: Primary Care Practice Support.
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
Experimental: Cluster C
50 practices randomly assigned to start intervention at month 12. Assigned Intervention: Primary Care Practice Support.
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
Experimental: Cluster D
50 practices randomly assigned to start intervention at month 14.
Assigned Intervention: Primary Care Practice Support.
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
Experimental: Cluster E
50 practices randomly assigned to start intervention at month 16.
Assigned Intervention: Primary Care Practice Support.
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
The intervention consists of practice facilitation, academic detailing, and regional learning collaboratives.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurable reduction in arteriosclerotic cardiovascular disease (ASCVD) risk
Time Frame: 18 months
|
By comparing EHR data at baseline and post-intervention, determine whether practice support resulted in discernible reduction in CVD risk.
|
18 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sam Cykert, MD, UNC Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-0479
- 1R18HS023912-01 (U.S. AHRQ Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
Morehouse School of MedicineNot yet recruiting
-
Yonsei UniversityRecruitingCardiovascular DiseaseKorea, Republic of
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
National Human Genome Research Institute (NHGRI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States
Clinical Trials on Primary Care Practice Support
-
Massachusetts General HospitalCenters for Disease Control and Prevention; Harvard School of Public Health... and other collaboratorsCompleted
-
Shanghai 6th People's HospitalUniversity of North Carolina, Chapel Hill; Merck FoundationCompletedPreDiabetes | Type2 DiabetesChina
-
Hospital de Clinicas de Porto AlegreCompleted
-
Kelli StajduharCanadian Cancer Society (CCS); Canadian Frailty NetworkCompletedFamily Caregiving for a Palliative PatientCanada
-
QualiCCareNovo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Primary CareSwitzerland
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Ministry of Health, Brazil; Conselho...Unknown
-
University Hospital, GenevaHaute Ecole de Santé Vaud; University of Applied Sciences of Western Switzerland and other collaboratorsRecruiting
-
Gerencia de Atención Primaria, MadridCompleted
-
University of Colorado, DenverUniversity of New MexicoCompletedCardiovascular DiseasesUnited States
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedType 2 Diabetes | Cardiovascular Risk Factor | GenderSpain